Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or South Carolina for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to South Carolina only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. South Carolina (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Jennifer Douglas (NPI 1023044906)

Field	Value
Entity Type	Individual
Organization	Jennifer Douglas
Address	171 Ashley Ave
City	Charleston
State	SC
ZIP	29425
Taxonomy	Physician Assistant
NPI Enumerated	June 23, 2006

Payer Source	Total Paid
Medicare	$2.9M
Medicaid	$0

Key Findings

This provider’s Medicare billing is highly concentrated in high-cost biologic and infusion drugs: J9271 (pembrolizumab) accounts for $1.4M in Medicare revenue with 31.4K claims and represents 46.2% of the provider’s total Medicare revenue, while J1569 (immune globulin) contributes $728.6K from 20.2K claims (24.9%) and J0897 (denosumab) contributes $382.3K from 21.2K claims (13.1%). The precomputed top-3 concentration is 84.2% of Medicare revenue, indicating the practice’s financial profile is dominated by a narrow set of infusion/biologic services rather than a broad mix of office or procedural care.

The code mix and highest-revenue items point to an infusion- or oncology-focused operation that routinely administers immunotherapy and high-volume biologics: J9271 (pembrolizumab) and J1569 (gammagard liquid) are both oncology/immunology injectable products, and the presence of chemotherapy administration codes such as 96413 and add-on infusion codes (96417, 96415) supports regular infusion therapy workflows. This profile implies substantial drug acquisition, inventory management, and buy-and-bill cashflow implications for the provider’s operations and payer contracting.

Competitive standing for the top drugs is unusually strong at a national level: J1569 ranks #9 of 542 providers nationally (99th percentile) and is flagged as notably above typical national volume, and J9271 ranks #108 of 1841 providers (94th percentile) also noted as notably above typical national volume. J0897 ranks #256 of 10057 providers (97th percentile) and is likewise above typical national volume, together indicating this provider is a high-volume national participant for multiple infusion biologics rather than a low-volume local clinic for these agents.

While several accessory infusion and chemotherapy administration codes show typical volumes, a small number of non-drug codes are statistical outliers and imply high throughput for specific administration activities: 96372 is reported as an "extreme outlier" (846 claims, $6.8K revenue, ranks #590 of 58224 providers, 99th percentile), suggesting frequent use of injection/administration services beyond what peers report. Other administration codes such as 96365, 96366 and 96374 appear in typical ranges, reinforcing that the standout volumes are concentrated in a few specific services and drugs.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $2.9M and there is no Medicaid billing on file, so the provider’s publicly visible payer exposure is concentrated in Medicare populations. This single-payer profile reduces Medicaid-facing risk but increases sensitivity to Medicare reimbursement policies and any shifts in coverage or pricing for high-cost biologics.

Tenure and enrollment stability are long-standing: the NPI was enumerated on 2006-06-23 (approximately 20 years ago), indicating sustained participation in Medicare over an extended period and suggesting operational experience with Medicare billing and infusion therapy workflows. Long tenure can be relevant when assessing historical contract performance and operational continuity.

There is a mixed picture for other specialty drugs: J9312 (rituximab) and J1745 (infliximab) appear at typical or unremarkable national volumes (J9312 ranks in the 35th percentile; J1745 in the 78th percentile), which suggests the provider focuses selectively on certain biologics (pembrolizumab, immune globulin, denosumab) rather than uniformly high volume across all infusion oncology agents. This selective concentration can influence competitor comparisons and supplier negotiations for the specific high-use products.

Operational and contracting implications follow from the revenue pattern: with $1.4M tied to J9271 and $728.6K tied to J1569 alone, payer negotiations, specialty pharmacy sourcing, and inventory financing should prioritize those agents because they drive the majority of Medicare revenue. The provider’s high national ranks for those codes (including a top-10 national rank for J1569) make it a notable counterparty for payers and vendors focused on immunoglobulin and immunotherapy utilization.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	31,400	$40	$1.4M
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	20,240	$40	$728.6K
J0897	Injection, denosumab, 1 mg	21,240	$20	$382.3K
J9312	Injection, rituximab, 10 mg	2,500	$60	$157.5K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	5,670	$30	$147.4K
J1439	Injection, ferric carboxymaltose, 1 mg	73,400	$1	$73.4K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	510	$80	$39.1K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	340	$40	$12.7K
96372	A therapeutic, prophylactic, or diagnostic substance (a fluid, a drug, etc.) is injected via intramuscular or subcutaneous route into the patient's body. The procedure is performed by the physician…	850	$10	$6.8K
96366	The provider administers an intravenous infusion or infusions of a medication for an additional hour or subsequent hours after the first hour to prevent, treat, or diagnose a condition or disease.	460	$10	$5.5K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. South Carolina Distribution

Jennifer Douglas — 6 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — South Carolina

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	1	30	19,700	$40	$832K
J9312	10	20	2,340	$60	$193.7K
J1569	1	20	3,860	$40	$161.4K
J1745	10	50	3,250	$30	$107K
J0897	13	250	2,400	$20	$91.2K
J1439	6	30	42,750	$1	$42.3K
96413	20	150	140	$90	$22.1K
96367	39	50	230	$20	$9.2K
96365	24	170	100	$40	$7.4K
96417	33	40	140	$50	$7.2K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Jennifer Douglas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Medical University Hospital Authority	SC	General Acute Care Hospital	$0	$241.1M
University Medical Associates Of The Medical University Of South Carol	SC	Family Medicine Physician	$0	$56.6M
Medical University Hospital Authority	SC	Psychologist	$0	$32.6M
Medical University Hospital Authority	SC	General Acute Care Hospital	$0	$28.3M
Musc Community Physicians	SC	Internal Medicine Physician	$0	$16.7M
Providence Hospital, LLC	SC	General Acute Care Hospital	$0	$12.7M
Medical University Hospital Authority	SC	Pediatrics Physician	$0	$12.4M
Medical University Hospital Authority	SC	General Acute Care Hospital	$0	$12.1M
University Medical Associates	SC	Pediatrics Physician	$0	$9.2M
Medical University Hospital Authority	SC	General Acute Care Hospital	$0	$8.7M

Nearby Providers

Other providers in the same ZIP code as Jennifer Douglas, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Musc Affiliate Physicians	SC	Family Medicine Physician	$0	$14.7M
University Medical Associates Of The Medical University Of South Carol	SC	Obstetrics & Gynecology Physician	$0	$6.1M
University Medical Associates Of The Medical University Of South Carol	SC	Diagnostic Radiology Physician	$0	$5.4M
University Medical Associates Of The Medical University Of South Carol	SC	Emergency Medicine Physician	$0	$3.6M
University Medical Associates Of The Medical University Of South Carol	SC	Pediatrics Physician	$0	$3.5M
University Medical Associates Of The Medical University Of South Carol	SC	Psychiatry Physician	$0	$3.3M
Rosalee Unwin	SC	Family Nurse Practitioner	$2.9M	$0
University Medical Associates Of The Medical University Of South Carol	SC	Multi-Specialty Clinic/Center	$0	$2.8M
Woodrow Coker	SC	Hospitalist Physician	$2.6M	$0
University Medical Associate Of The Medical University Of South Caroli	SC	Otolaryngology Physician	$0	$2.3M

Jennifer Douglas — Billing Profile & Reimbursement Data

Sign up for Jennifer Douglas — Billing Profile & Reimbursement Data policy alerts

Jennifer Douglas — Billing Profile & Reimbursement Data

Sign up for Jennifer Douglas — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References